Authorised Therapeutic confirmatory (Phase III) chronic idiopathic ano-perineal pain

EFFICACY OF USUAL MANAGEMENT BY LOCAL ANESTHETIC INFILTRATION IN THE TREATMENT OF CHRONIC IDIOPATHIC ANO-PERINEAL PAIN: A RANDOMIZED DOUBLE-BLIND -CONTROLLED TRIAL

EU CTIS ID: 2024-518148-19-00

What this study is testing

evaluate the efficacy of posterior perineal block performed under neurostimulation on pain 1 month after local anesthetic infiltration in the treatment of chronic idiopathic ano-perineal pain.

  • Therapeutic confirmatory (Phase III)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Patient 18 years of age or older
  • Express consent to participate in the study
  • Affiliated or beneficiary of a social security plan
  • Presenting chronic idiopathic ano-perineal pain
  • Normal MRI or no pathology explaining pain
  • Resistance to “standard” 1st-line medical treatment (1 or 2 analgesics and/or NSAIDs and/or local topicals).

You likely can't join if

  • Patient under legal protection
  • Pregnant or breast-feeding woman
  • Current general and/or local infection (fistulous or cutaneous suppuration of anal margin)
  • Known neurological pathology that may explain pain
  • Psychiatric pathology requiring medication
  • Anticoagulants or haemostasis disorders
See the full eligibility criteria
Who can join
  • Patient 18 years of age or older
  • Express consent to participate in the study
  • Affiliated or beneficiary of a social security plan
  • Presenting chronic idiopathic ano-perineal pain
  • Normal MRI or no pathology explaining pain
  • Resistance to “standard” 1st-line medical treatment (1 or 2 analgesics and/or NSAIDs and/or local topicals).
What rules you out
  • Patient under legal protection
  • Pregnant or breast-feeding woman
  • Current general and/or local infection (fistulous or cutaneous suppuration of anal margin)
  • Known neurological pathology that may explain pain
  • Psychiatric pathology requiring medication
  • Anticoagulants or haemostasis disorders
  • Hypersensitivity to lidocaine hydrochloride or local anesthetics
  • Recurrent porphyrias

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.